Literature DB >> 10559617

Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia.

V Scattoni1, M Raber, F Montorsi, L Da Pozzo, M Brausi, G Calori, M Freschi, P Rigatti.   

Abstract

PURPOSE: To determine which pathologic features of the surgical specimen in men undergoing open prostatectomy for benign prostatic hyperplasia (BPH) correlate with preoperative and postoperative total, free prostate-specific antigen (PSA) levels and the free-to-total PSA ratio.
METHODS: Forty-four patients, undergoing open prostatectomy for BPH without evidence of prostate cancer in systematic biopsies and clinical prostatitis, were included in this prospective study. Each prostatectomy specimen was weighed and each slide was evaluated for inflammation (acute prostatitis, chronic-active prostatitis and chronic-inactive prostatitis), prostatic intraepithelial neoplasia, transitional/squamous metaplasia, cystic ductal dilation, leiomyoma-resembling stromal cell proliferation, leakage of prostatic secretion, infarction and prostatic calculi.
RESULTS: The mean preoperative (and postoperative) total PSA and free PSA levels were 6.1 +/- 4.3 (1.14 +/- 0.87) and 1.7 +/- 1.6 (0.24 +/- 0.19) ng/ml, respectively. The mean prostatic and transition zone volume was 83.9 +/- 28.4 and 55.4 +/- 27.6 cm(3), respectively. Both total PSA and free PSA levels were correlated with total gland volume (p = 0.0001; p = 0.002) and the volume of the surgical specimen (p = 0.003; p < 0.05) and, upon stepwise logistic analysis, patients with a total gland volume of <50 cm(3) had an odds ratio of 11 (CI 1.6-71.3) for having a free-to-total ratio of <18%. No minimal change pathology or prostatic inflammation were associated with preoperative total or free PSA levels. The free-to-total PSA ratio was higher in the group of patients with histologically acute and moderate to severe chronic-active prostatitis (mean ratio 27 +/- 12%) than in patients with chronic-inactive prostatitis and minimal chronic-active prostatitis (mean ratio 0.19 +/- 13%; p = 0.05), showing an odds ratio of 5 (CI 1.1-22.1) for having a free-to-total PSA ratio of <18%.
CONCLUSIONS: Prostate volume and, in particular, transition zone volume seem to influence both free and total PSA levels in men with BPH. The free-to-total PSA ratio seems to be influenced by the presence of histological prostatitis in the surgical specimen. In particular, patients with a prostate volume of <50 cm(3) and an inactive form of prostatitis seem to have a relatively higher risk of having a free-to-total PSA ratio of <18%. Copyright 1999 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559617     DOI: 10.1159/000020057

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  4 in total

1.  Changes in S-PSA after transurethral resection of prostate and its correlation to postoperative outcome.

Authors:  Mrinal Pahwa; Mayank Pahwa; Archna R Pahwa; Mohit Girotra; Arun Chawla; Ajay Sharma
Journal:  Int Urol Nephrol       Date:  2013-05-24       Impact factor: 2.370

2.  Effect of histological inflammation on total and free serum prostate-specific antigen values in patients without clinically detectable prostate cancer.

Authors:  Goran Stimac; Borislav Spajic; Ante Reljic; Josip Katusic; Alek Popovic; Igor Grubisic; Davor Tomas
Journal:  Korean J Urol       Date:  2014-08-08

3.  Impact of perioperative factors on nadir serum prostate-specific antigen levels after holmium laser enucleation of prostate.

Authors:  Mary Martos; Jonathan E Katz; Madhumita Parmar; Anika Jain; Nachiketh Soodana-Prakash; Sanoj Punnen; Mark L Gonzalgo; Feng Miao; Isildinha M Reis; Nicholas Smith; Hemendra N Shah
Journal:  BJUI Compass       Date:  2021-01-05

Review 4.  Are all procedures for benign prostatic hyperplasia created equal? A systematic review on post-procedural PSA dynamics and its correlation with relief of bladder outlet obstruction.

Authors:  Abhishek Bhat; Ruben Blachman-Braun; Thomas R W Herrmann; Hemendra N Shah
Journal:  World J Urol       Date:  2021-07-02       Impact factor: 3.661

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.